Aerial Release of Mosquitoes
- Funded by European Commission
- Total publications:0 publications
Grant number: 899888
Grant search
Key facts
Disease
Unspecified, UnspecifiedStart & end year
20202022Known Financial Commitments (USD)
$179,805Funder
European CommissionPrincipal Investigator
N/A
Research Location
FranceLead Research Institution
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPICResearch Priority Alignment
N/A
Research Category
Animal and environmental research and research on diseases vectors
Research Subcategory
Vector biology
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
MOSQUAREL (Aerial Release of Mosquitoes) The REVOLINC project (ERC Consolidator grant no. 682387) aims at developing environmentally-friendly alternatives to fight insects invasions through the development of biological technologies to control three types of pest insects (mosquitoes, tsetse flies and Mediterranean fruit flies), two of which are presently invading Europe. We want to improve the << sterile insect technique >> which consists in mass rearing male insects, sterilizing them by radiation and releasing them into the environment, where they compete with their wild, non-sterile counterparts to reproduce. The << boosted sterile insect technique >> consists in ensuring that the males also transmit biopesticides to the females that kill them or their progeny. It is mandatory to develop alternative methods to insecticides that raise concern for their toxicity for health and environment, particularly against mosquito vectors in the context of Zika virus epidemics. The proposed technology necessitates the release of sterile males, preferably by air. There is presently no aerial system to release mosquitoes which are all released by ground using obsolete methods (cages open at the back of a vehicle...). In the proposed PoC, we want to (1) initiate collaboration with a private company to produce two versions of mosquito releasing drones compliant with EU regulations (C1 and C2 classes), (2) confirm the efficiency of these systems to release sterile male Aedes albopictus in three sites (La Réunion island and Montpellier in France and Valencia in Spain) and (3) start the commercialization process for these drones. The system will become available for other mosquito control technologies involving the release of mosquitoes transfected with symbionts blocking virus transmission or transgenic mosquitoes.